ITCI
TD Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-72,648
| Closed | -$5.2M | – | 1446 |
|
2023
Q4 | $5.2M | Buy |
+72,648
| New | +$5.2M | 0.01% | 756 |
|
2020
Q4 | – | Sell |
-16,916
| Closed | -$434K | – | 1484 |
|
2020
Q3 | $434K | Sell |
16,916
-6,412
| -27% | -$165K | ﹤0.01% | 1271 |
|
2020
Q2 | $599K | Sell |
23,328
-12,400
| -35% | -$318K | ﹤0.01% | 1181 |
|
2020
Q1 | $549K | Buy |
35,728
+5,728
| +19% | +$88K | ﹤0.01% | 1157 |
|
2019
Q4 | $1.03M | Buy |
+30,000
| New | +$1.03M | ﹤0.01% | 1085 |
|
2019
Q3 | – | Sell |
-14,900
| Closed | -$193K | – | 1374 |
|
2019
Q2 | $193K | Buy |
14,900
+700
| +5% | +$9.07K | ﹤0.01% | 1300 |
|
2019
Q1 | $173K | Hold |
14,200
| – | – | ﹤0.01% | 1313 |
|
2018
Q4 | $162K | Sell |
14,200
-6,900
| -33% | -$78.7K | ﹤0.01% | 1362 |
|
2018
Q3 | $458K | Sell |
21,100
-16,600
| -44% | -$360K | ﹤0.01% | 1308 |
|
2018
Q2 | $666K | Sell |
37,700
-11,400
| -23% | -$201K | ﹤0.01% | 1210 |
|
2018
Q1 | $1.03M | Buy |
+49,100
| New | +$1.03M | ﹤0.01% | 1051 |
|
2017
Q2 | – | Sell |
-14,000
| Closed | -$228K | – | 1377 |
|
2017
Q1 | $228K | Sell |
14,000
-1,300
| -8% | -$21.2K | ﹤0.01% | 1356 |
|
2016
Q4 | $231K | Buy |
15,300
+1,100
| +8% | +$16.6K | ﹤0.01% | 1325 |
|
2016
Q3 | $216K | Buy |
+14,200
| New | +$216K | ﹤0.01% | 1355 |
|